DR. THOMAS JOHN BARANSKI, MD
Osteopathic Medicine at Childrens Pl, Saint Louis, MO
License number
Missouri 2000154619
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
4570 Childrens Pl, Saint Louis, MO 63110
Phone
(314) 362-3500
(314) 362-3454 (Fax)
(314) 362-3454 (Fax)
Personal information
See more information about THOMAS JOHN BARANSKI at radaris.comName
Address
Phone
819 Craig Forest Ln, Saint Louis, MO 63122
819 Craig Forest Ln, Saint Louis, MO 63122
Professional information
Dr. Thomas J Baranski, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
Saint Louis Office
660 S Euclid Ave, Saint Louis 63110
(314) 362-5000 (Phone), (314) 454-5396 (Fax)
Washington University Endo
4921 Parkview Pl SUITE C, Saint Louis 63110
(314) 362-3500 (Phone)
Medicine Multispecialty Center
4921 Parkview Pl SUITE 5C, Saint Louis 63110
(314) 747-9150 (Phone)
660 S Euclid Ave, Saint Louis 63110
(314) 362-5000 (Phone), (314) 454-5396 (Fax)
Washington University Endo
4921 Parkview Pl SUITE C, Saint Louis 63110
(314) 362-3500 (Phone)
Medicine Multispecialty Center
4921 Parkview Pl SUITE 5C, Saint Louis 63110
(314) 747-9150 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2011, Internal Medicine, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1992
University Of California-San Francisco
Washington Center / School of Medicine
Graduated: 1992
University Of California-San Francisco
Associate Professor, Washington University School Of Medicine
Location:
Greater St. Louis Area
Industry:
Biotechnology
Thomas John Baranski, Saint Louis MO
Specialties:
Endocrinologist
Address:
4570 Childrens Pl, Saint Louis, MO 63110
Education:
Washington University, School of Medicine - Doctor of Medicine*
UCSF Medical Center - Residency - Internal Medicine*
UCSF Medical Center - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)*
Thomas John Baranski, Saint Louis MO
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism
Work:
Washington University at St. Louis
4570 Childrens Pl, Saint Louis, MO 63110
4570 Childrens Pl, Saint Louis, MO 63110
Education:
Washington University at St. Louis (1992)
High Throughput Cancer Pharmaceutical Screening Using Drosophila
US Patent:
2006001, Jan 12, 2006
Filed:
Jun 16, 2005
Appl. No.:
11/154035
Inventors:
Thomas Baranski - Kirkwood MO, US
Ross Cagan - Clayton MO, US
Ross Cagan - Clayton MO, US
International Classification:
A01K 67/033
US Classification:
800010000, 800013000
Abstract:
High throughput drug screening assay methods and related apparatus are described. with screenably distinct characteristics are raised in multi-well microtiter plates on standard growth medium. Screenably distinct characteristics which mimic human cancer or cancer-related condition are established by modifying expression of an oncogene or tumor suppressor in the . Compounds that putatively modify the screenably distinct characteristic are then tested by feeding the compounds to the embryos, and determining whether the compound modifies the screenably distinct characteristic induced by modifying gene expression. The assay methods and related articles of composition can also be used to simultaneously assay toxicity of candidate compounds.
High Throughput Pharmaceutical Screening Using Drosophila
US Patent:
2005026, Nov 24, 2005
Filed:
Jan 14, 2005
Appl. No.:
11/036897
Inventors:
Thomas Baranski - Kirkwood MO, US
Ross Cagan - Clayton MO, US
Ross Cagan - Clayton MO, US
International Classification:
A61K049/00
US Classification:
424009200
Abstract:
High throughput drug screening assay methods and related apparatus are described. Wild-type are raised in multi-well microtiter plates on a growth medium having a high level of a sugar such as glucose. The high sugar diet during development induces screenably distinct characteristics in the wild-type . Compounds that putatively modify the screenably distinct characteristic are tested by feeding to the embryos, and determining whether the compound modifies the screenably distinct characteristic induced by the high sugar growth medium. The assay methods and related articles of composition can also be used to assay toxicity of candidate compounds.
Osteopathic Medicine licenses in Missouri
DAVID WILLIAM HORAN, Osteopathic Medicine, 1401 S Brentwood Blvd Suite 835 St, Saint Louis, MO 63144